KCNK3 and atrial fibrillation: For acute cardioversion of paroxysmal or persistent AF, the DOCTOS trial (doxapram conversion to SR; EudraCT No: 2018-002979-17) currently evaluates whether TASK-1 inhibition might serve as a strategy for AF treatment.